OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

OriGene Antibodies in recent publications
Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas Blood, Mar 2013; 121: 2563 - 2566. [anti-HA]

Regulation of the PI3-K/Akt Survival Pathway in the Rat Endometrium Biol Reprod, Mar 2013; 88: 79. [Akt3]

RNA elements directing in vivo assembly of the 7SK/MePCE/Larp7 transcriptional regulatory snRNP Nucleic Acids Res., Mar 2013; 10.1093/nar/gkt159. [LA]

Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements Haematologica, Mar 2013; 98: 404 - 408. [JAK2]

View All Citations >>
Home All anti-OR2T35 antibodies

Anti-OR2T35 Antibody

div

Specifications Related Products Conjugation/Bulk FAQs
SKU Description Amount Price Availability*  
TA316460
  • Rabbit polyclonal OR2T2/2T35 antibody
100ul $325 2 Weeks Add to Shopping Cart
WB(1)
spacer
Also for OR2T35 (NM_001001827)
cDNA Clone shRNA/siRNA Lysate Protein Request Antibody
Gene NameHomo sapiens olfactory receptor, family 2, subfamily T, member 35 (OR2T35)
Synonyms:
ImmunogenThe antiserum was produced against synthesized peptide derived from internal of human OR2T2/2T35.
BufferPhosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Clone Name IsotypeIgG
Species ReactivityHuman Concentration1mg/ml
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. (Protein A or G Sepharose)
Guaranteed Application *WB Suggested DilutionsWB: 1:500~1:3000, ELISA: 1:1000
BackgroundOR2T2/2T35 antibody detects endogenous levels of total OR2T2/2T35 protein.
Related Pathway
Signaling by GPCR

* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

WB Image
Western blot analysis of extracts from HUVEC cells, using OR2T2/2T35 antibody.The lane on the right is treated with the synthesized peptide.

 

spacer
Inc 5000 Healthcare Company Copyright © 2013 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title